Extension of Time to File SOU

SAMIAIR

NeuroRx, Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90179858
LAW OFFICE ASSIGNED LAW OFFICE 105
MARK SECTION
MARK SAMIAIR (see, http://uspto.report/TM/90179858/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT SAMIAIR
OWNER SECTION (current)
NAME NeuroRx, Inc.
MAILING ADDRESS 913 North Market Street
CITY Wilmington
STATE Delaware
ZIP/POSTAL CODE 19801
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 202-340-1352
EMAIL XXXX
OWNER SECTION (proposed)
NAME NeuroRx, Inc.
MAILING ADDRESS 1201 North Market Street, Suite 111
CITY Wilmington
STATE Delaware
ZIP/POSTAL CODE 19801
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 202-340-1352
EMAIL XXXX
ATTORNEY INFORMATION (new)
NAME Brian J. Del Buono
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Del Buono Legal, PLLC
STREET 19228 Charandy Drive
CITY Leesburg
STATE Virginia
POSTAL CODE 20175
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 17034025866
EMAIL bdelbuono@nrxpharma.com
CORRESPONDENCE INFORMATION (current)
NAME NEURORX, INC.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE jjavitt@neurorxpharma.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) jjavitt@jhu.edu; bdelbuono@neurorxpharma.com
CORRESPONDENCE INFORMATION (proposed)
NAME Brian J. Del Buono
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE bdelbuono@nrxpharma.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) jjavitt@nrxpharma.com; adaigneault@nrxpharma.com; mkunz@nrxpharma.com
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of Sarcoidosis; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations, namely, antivirals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with Vasoactive Intestinal Peptide
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 02/23/2021
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /Brian J. Del Buono/
SIGNATORY'S NAME Brian J. Del Buono
SIGNATORY'S POSITION Attorney of Record, Virginia Bar member
DATE SIGNED 08/16/2021
SIGNATORY'S PHONE NUMBER 7034028566
SIGNATURE METHOD Signed directly within the form
FILING INFORMATION
SUBMIT DATE Mon Aug 16 11:45:49 ET 2021
TEAS STAMP USPTO/ESU-XXXX:XXXX:XXXX:
XXXX:XXXX:XXXX:XXXX:XXXX-
20210816114549745135-9017
9858-781b757bc5cff90b2c44
ea9f8c0eb76e4d825f9043694
c752758c6c24cd193f69-CC-4
5462309-20210816114027561
230



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: SAMIAIR (see, http://uspto.report/TM/90179858/mark.png)
SERIAL NUMBER: 90179858

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: NeuroRx, Inc., having an address of
      913 North Market Street
      Wilmington, Delaware 19801
      United States
      Phone: 202-340-1352
      Email: XXXX
Proposed: NeuroRx, Inc., having an address of
      1201 North Market Street, Suite 111
      Wilmington, Delaware 19801
      United States
      Phone: 202-340-1352
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 02/23/2021.

For International Class 005:
Current identification: Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of Sarcoidosis; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations, namely, antivirals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with Vasoactive Intestinal Peptide

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      NEURORX, INC.
      PRIMARY EMAIL FOR CORRESPONDENCE: jjavitt@neurorxpharma.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jjavitt@jhu.edu; bdelbuono@neurorxpharma.com

Correspondence Information (proposed):
      Brian J. Del Buono
      PRIMARY EMAIL FOR CORRESPONDENCE: bdelbuono@nrxpharma.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): jjavitt@nrxpharma.com; adaigneault@nrxpharma.com; mkunz@nrxpharma.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

The applicant hereby appoints Brian J. Del Buono of  Del Buono Legal, PLLC
      19228 Charandy Drive
      Leesburg, Virginia 20175
      United States


      The phone number is 17034025866.
      PRIMARY EMAIL: bdelbuono@nrxpharma.com
      SECONDARY EMAIL: NOT PROVIDED
to submit this Request for Extension of Time to File a Statement of Use on behalf of the applicant.



A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Brian J. Del Buono/      Date Signed: 08/16/2021
Signatory's Name: Brian J. Del Buono
Signatory's Position: Attorney of Record, Virginia Bar member
Signatory's Phone: 7034028566
Signature method: Signed directly within the form

Mailing Address:
   Del Buono Legal, PLLC
   
   19228 Charandy Drive
   Leesburg, Virginia 20175

PAYMENT: 90179858
PAYMENT DATE: 08/16/2021

Serial Number: 90179858
Internet Transmission Date: Mon Aug 16 11:45:49 ET 2021
TEAS Stamp: USPTO/ESU-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20210816114549745135-90179858-
781b757bc5cff90b2c44ea9f8c0eb76e4d825f90
43694c752758c6c24cd193f69-CC-45462309-20
210816114027561230




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed